Acetylcysteine Ophthalmic Solution
Lack of sterility assurance.
11,818 recalls · Class II, newest first
Lack of sterility assurance.
Lack of Processing Controls.
Lack of Processing Controls.
Lack of Processing Controls.
Lack of Processing Controls.
Lack of Processing Controls.
Lack of Processing Controls.
Failed Dissolution Specifications.
Labeling: Wrong bar code
Superpotent Drug: contains higher levels of Iron than labeled.
Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.
GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample
GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample
GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample
Superpotent Drug.
Sub-potent
Sub-potent
Presence of foreign tablet/capsule: A single foreign tablet was found in pharmacy dispensed bottle of 30 Estradiol 2 mg tablets.
Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Superpotent Drug: recalled lots may have higher concentration of ibuprofen.
Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas aeruginosa in product
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
cGMP violations noted during the firm's most recent inspection.
cGMP violations noted during the firm's most recent inspection.